Table 2.
Estimated HCV prevalence in general populations in African countries
| Country | Sample size | HCV Prevalence (%) (CI) | Genotype |
|---|---|---|---|
| Central Africa | |||
| Burundi | 1184 | 11.3 (4.9 – 33.3) | 4 |
| Cameroon | 6015 | 13.8(0.0 – 40.0) | 4 |
| CAR | 709 | 2.4(0.0-6.1) | 4 |
| Chad | 290 | 4.8(2.4-5.8) | 4 |
| Congo | 0 | (2.5-9.2) | 4 |
| DRC | 2572 | 5.5(4.3-6.6) | 4 |
| Equatorial Guinea | 2042 | 1.7(1.7-1.7) | 4 |
| Gabon | 1597 | 9.2(6.5-16.5) | 4 |
| Rwanda | 610 | 4.1(0.9-17.0) | 4 |
| Sudan | 865 | 2.8(1.5-3.2) | 4 |
| Uganda | 881 | 6.6(0.0-14.2) | 4 |
| Total | 16765 | 6.0(0.0-40.0) | 4 |
| West Africa | |||
| Benin | 1110 | 1.6(0.0-4.0) | 1-3 |
| Burkina Faso | 965 | 4.9(2.2-8.3) | 1-3 |
| Cote d'Ivoire | 429 | 3.3(3.3-8.2) | 1-3 |
| Gambia | 212 | 2.4(2.4-2.4) | 1-3 |
| Ghana | 5033 | 1.7(0.1-5.4) | 1-3 |
| Guinea | 2050 | 5.5(0.8-8.7) | 1-3 |
| Mauritania | 349 | 1.1(1.1-1.1) | 1-3 |
| Niger | 2327 | 1.8(0.0-7.6) | 1-3 |
| Nigeria | 669 | 2.1(0.0-5.8) | 1-3 |
| Senegal | 352 | 2.2(0.0-7.3) | 1-3 |
| Togo | 478 | 3.9(1.3-6.1) | 1-3 |
| Total | 13974 | 2.4(0.0-8.7) | 1-3 |
| South and east Africa | |||
| Eritrea | 323 | 1.9(0.0-6.0) | 1-3 |
| Ethiopia | 2080 | 1.9(0.6-3.4) | 1-3 |
| Kenya | 1567 | 0.9(0.0-1.0) | 1-3 |
| Madagascar | 1564 | 2.1(1.2-3.3) | |
| Malawi | 140 | 0.7(0.7-0.7) | |
| Mozambique | 536 | 2.8(2.1-3.2) | |
| Somalia | 2203 | 1.5(0.0-7.0) | |
| South Africa | 68931 | 0.1(0.0-3.5) | 5 |
| Swaziland | 194 | 1.5(1.5-1.5) | |
| Tanzania | 2188 | 3.2(0.5-8.6) | 5 |
| Zambia | 583 | 0.2(0.0-0.3) | 5 |
| Zimbabwe | 579 | 2.0(0.2-7.7) | |
| S & E Africa total | 80888 | 1.6(0.0-8.6) | 5 |
| * North Africa | |||
| Egypt | 17.5(13-22) | 4 | |
| Sudan | 3 | 4 | |
| Libya | 1.2 | 4/1 | |
| Tunisia | 0.55(0.4-0.7) | 1b | |
| Algeria | 1.8 | NA | |
| Mauritania | 1.8 | NA | |
| Morocco | 7.7 | 1b | |
*
no available data on sample size and confidence interval for some countries